Bjork Elisabeth
Director
PurchaseAlert
- Shares
- 10,000
- Price
- $3.44
- Value
- $34,400
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•62 filings
RCKT
ROCKET PHARMACEUTICALS, INC.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$34,400
1 distinct insiders
12-month sales
$34,463
4 distinct insiders
Highlighted alerts
10
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get RCKT insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
RCKT overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
10
Voluntary view
P/S trades after deterministic checks
68
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 75,364
- Price
- $3.40
- Footnotes
- 2
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Militello John
See Remarks
SaleAlert
- Shares
- 1,086
- Price
- $2.98
- Value
- $3,240
Schwartz Jonathan David
See Remarks
SaleAlert
- Shares
- 2,545
- Price
- $2.98
- Value
- $7,592
Shah Gaurav
CEO
SaleAlert
- Shares
- 6,276
- Price
- $2.98
- Value
- $18,721
Wilson Martin
General Counsel
SaleAlert
- Shares
- 1,646
- Price
- $2.98
- Value
- $4,910
Militello John
See Remarks
SaleAlert
- Shares
- 558
- Price
- $3.98
- Value
- $2,218
Militello John
See Remarks
SaleAlert
- Shares
- 3,005
- Price
- $3.97
- Value
- $11,930
Militello John
See Remarks
SaleAlert
- Shares
- 5,514
- Price
- $3.97
- Value
- $21,863
Militello John
See Remarks
SaleAlert
- Shares
- 19,841
- Price
- $3.96
- Value
- $78,570
Bjork Elisabeth
Director
PurchaseAlert
- Shares
- 10,000
- Price
- $3.41
- Value
- $34,100
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jan 02, 2026 | Bjork Elisabeth Director | Purchase | 10,000 | $3.44 | $34,400 | |
| Nov 18, 2025 | Militello John See Remarks | Sale | 1,086 | $2.98 | $3,240 | |
| Nov 18, 2025 | Schwartz Jonathan David See Remarks | Sale | 2,545 | $2.98 | $7,592 | |
| Nov 18, 2025 | Shah Gaurav CEO | Sale | 6,276 | $2.98 | $18,721 | |
| Nov 18, 2025 | Wilson Martin General Counsel | Sale | 1,646 | $2.98 | $4,910 | |
| Oct 14, 2025 | Militello John See Remarks | Sale | 558 | $3.98 | $2,218 | |
| Oct 14, 2025 | Militello John See Remarks | Sale | 3,005 | $3.97 | $11,930 | |
| Oct 14, 2025 | Militello John See Remarks | Sale | 5,514 | $3.97 | $21,863 | |
| Oct 14, 2025 | Militello John See Remarks | Sale | 19,841 | $3.96 | $78,570 | |
| Aug 27, 2025 | Bjork Elisabeth Director | Purchase | 10,000 | $3.41 | $34,100 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.